Arlington Capital Partners acquires AVS Bio from Charles River Laboratories
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories. The terms of the transaction were not disclosed. The new entity dubbed as AVS Bio will operate independently as a standalone platform for Arlington Capital Partners, and serve the biologic manufacturing and bioprocessing markets. AVS Bio offers […]